Summary of AML patient characteristics
AML . | PB/BM . | % CD34 . | Flt3-ITD . | p-Stat5 . | FAB . | Risk group . | Karyotype . | Transduced . | CD34+ cells plated per T25 . | Growth until wk . | Expansion after Renilla RNAi . | Expansion after Stat5 RNAi . | Fold down-regulation . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | PB | 85 | − | + | M1 | Poor | +3q,−7, −10 | No | N/A | N/A | N/A | N/A | N/A |
2 | PB | 3 | − | − | M1 | Int | Normal | No | N/A | N/A | N/A | N/A | N/A |
3 | PB | 14 | − | + | M2 | Good | t(8;21) | No | N/A | N/A | N/A | N/A | N/A |
4 | PB | 15 | − | + | M4 | Poor | t(6;11)(q27;23) | No | N/A | N/A | N/A | N/A | N/A |
5 | PB | 69 | + | ± | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 25.0 | 15.6 | 1.6 |
6 | BM | 5 | + | − | M5b | Int | Normal | Yes | 2.2 × 105 | 4 | 4.2 | 5.7 | 0.7 |
7 | PB | 12 | + | + | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 9.7 | 4.0 | 2.4 |
8 | PB | 1 | + | + | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 8.1 | 2.4 | 3.4 |
9 | BM | nd | − | − | M4 | Int | Normal | Yes | 5.0 × 105 | 6 | 214.2 | 12.7 | 16.8 |
10 | BM | 80 | + | + | M1 | Good | inv(16) | Yes | 5.0 × 105 | 6 | 17.7 | 0.7 | 24.4 |
11 | BM | 5 | − | + | M4 | Poor | inv(16) | Yes | 5.0 × 105 | 6 | 207.1 | 67.1 | 3.1 |
12 | BM | 37 | nd | nd | M4 | Int | Normal | Yes | 2.2 × 105 | 4 | 7.6 | 1.6 | 4.8 |
13 | PB | 17 | + | nd | M2 | Poor | del 9, (q12;22) | Yes | 1.5 × 105 | 2, then † | N/A | N/A | N/A |
14 | BM | nd | − | − | M2 | Int | Normal | Yes | 5.0 × 105 | 2, then † | N/A | N/A | N/A |
15 | PB | 7 | + | − | M5b | Int | Normal | No | N/A | N/A | N/A | N/A | N/A |
16 | PB | 30 | + | nd | M1 | Int | Normal | Yes | N/A | N/A | N/A | N/A | N/A |
AML . | PB/BM . | % CD34 . | Flt3-ITD . | p-Stat5 . | FAB . | Risk group . | Karyotype . | Transduced . | CD34+ cells plated per T25 . | Growth until wk . | Expansion after Renilla RNAi . | Expansion after Stat5 RNAi . | Fold down-regulation . |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | PB | 85 | − | + | M1 | Poor | +3q,−7, −10 | No | N/A | N/A | N/A | N/A | N/A |
2 | PB | 3 | − | − | M1 | Int | Normal | No | N/A | N/A | N/A | N/A | N/A |
3 | PB | 14 | − | + | M2 | Good | t(8;21) | No | N/A | N/A | N/A | N/A | N/A |
4 | PB | 15 | − | + | M4 | Poor | t(6;11)(q27;23) | No | N/A | N/A | N/A | N/A | N/A |
5 | PB | 69 | + | ± | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 25.0 | 15.6 | 1.6 |
6 | BM | 5 | + | − | M5b | Int | Normal | Yes | 2.2 × 105 | 4 | 4.2 | 5.7 | 0.7 |
7 | PB | 12 | + | + | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 9.7 | 4.0 | 2.4 |
8 | PB | 1 | + | + | M5 | Int | Normal | Yes | 1.5 × 105 | 6 | 8.1 | 2.4 | 3.4 |
9 | BM | nd | − | − | M4 | Int | Normal | Yes | 5.0 × 105 | 6 | 214.2 | 12.7 | 16.8 |
10 | BM | 80 | + | + | M1 | Good | inv(16) | Yes | 5.0 × 105 | 6 | 17.7 | 0.7 | 24.4 |
11 | BM | 5 | − | + | M4 | Poor | inv(16) | Yes | 5.0 × 105 | 6 | 207.1 | 67.1 | 3.1 |
12 | BM | 37 | nd | nd | M4 | Int | Normal | Yes | 2.2 × 105 | 4 | 7.6 | 1.6 | 4.8 |
13 | PB | 17 | + | nd | M2 | Poor | del 9, (q12;22) | Yes | 1.5 × 105 | 2, then † | N/A | N/A | N/A |
14 | BM | nd | − | − | M2 | Int | Normal | Yes | 5.0 × 105 | 2, then † | N/A | N/A | N/A |
15 | PB | 7 | + | − | M5b | Int | Normal | No | N/A | N/A | N/A | N/A | N/A |
16 | PB | 30 | + | nd | M1 | Int | Normal | Yes | N/A | N/A | N/A | N/A | N/A |
PB indicates peripheral blood; BM, bone marrow; Flt3-ITD, Flt3 internal tandem duplication; FAB, French-American-British; nd, not determined; +, present; −, not present; and N/A, not applicable.